Appendix A: Multiple imputation of missing values for serum CA-125
In the available data, the serum CA-125 level was missing in 31% of the women. The value was more often missing in women with a benign tumour (36%) than in women with a borderline (18%) We used multiple imputation to handle the missing values in the analysis 1 : the missing CA-125 values were estimated (i.e. imputed) multiple times to acknowledge the uncertainty in the imputed values. To estimate the missing values, we used predictive mean matching regression 2 using variables that were related to either the level of CA-125 itself, or to the unavailability of CA-125 (i.e. a binary indicator indicating for each woman whether CA-125 was missing or not). This was repeated 100 times to generate multiple imputations of the missing values, resulting in 100 completed data sets. To reduce computational burden, we used only five of the completed datasets for variable selection. Differences in results between these five datasets were minimal. Subsequent model fitting was carried out on all 100 completed datasets and the resulting coefficients were averaged to obtain a final set of model coefficients.
We consider multiple imputation more appropriate than an analysis including only patients with information on CA-125 (complete case analysis). A complete case analysis will introduce bias: (1) because CA-125 is more often missing in patients with a tumour judged to be benign based on its ultrasound appearance, estimated risks for malignant tumour types will be too high, and (2) exclusion of these "easy" tumours will make the complete case sample more homogeneous and will therefore decrease model performance.
In addition to introducing bias, a complete case analysis would waste large amounts of precious data because there is complete information on all variables except CA-125.
Appendix B: Variable selection
Variable selection was performed in two stages. To avoid overfitting, we relied on subject matter knowledge to reduce the number of potential predictors. 3, 4 Clinicians with experience in diagnosing adnexal masses judged the available variables with respect to 'measurement harm' as well as their likely ability to differentiate between the four subtypes of malignant tumours. Measurement harm refers to issues such as subjectivity, dependency on operator experience, and burden for the patient. In addition we estimated to what extent the values of the variables varied between centres after controlling for tumour histology, in order to favour predictors with limited heterogeneity. 5 Finally, we aimed to include some baseline information on centre type, in order to improve the calibration of the estimated probabilities. All of these issues were taken into account when selecting variables. We selected four clinical variables, i.e. age (years), serum CA-125 (U/mL), family history of ovarian cancer (yes/no), and type of centre (oncology centre vs other hospitals), and six ultrasound variables, i.e. the maximum diameter of the lesion (mm), proportion of solid tissue (i.e. maximum diameter of the largest solid component divided by the maximum diameter of the lesion), the presence of more than 10 cyst locules (yes/no), number of papillary projections (0, 1, 2, 3, more than 3), presence of acoustic shadows (yes/no), and presence of ascites (yes/no). We believe that this a priori selection was sensible because it was done through collaboration between four experienced clinical researchers (DT, TB, CVH, LV).
The second stage of the variable selection procedure involved limited data-driven variable selection based on the method of multivariable fractional polynomials, which simultaneously selects variables and determines the optimal transformation of numerical variables using fractional polynomials. 6 The variable selection procedure (called RA2) is a variant of the standard backward selection procedure. The RA2 procedure was performed separately for the four submodels of the multinomial logistic regression model: Borderline versus Benign, Stage I cancer versus Benign, Stage II-IV cancer versus Benign, and Secondary metastatic cancer versus Benign. The variable selection analysis was carried out using logistic regression analysis with random centre intercepts.
As elimination criterion in the backward selection process and as criterion for the selection of functional form we used the p-value that mimicked the Bayesian Information Criterion, 4 in order to end up with a parsimonious model. We allowed a first degree polynomial for age, serum CA-125, the maximum diameter of the lesion, and the number of papillary projections. For the proportion of solid tissue a second degree polynomial was allowed because this is considered an important predictor that is of semi-continuous nature because a large number of tumours do not have a solid component. The final set of predictors for the polytomous model consisted of the variables that were selected in any of the four submodels. If different transformations were selected in the submodels, one final transformation was chosen. Two predictors were forced into the model and hence could not be eliminated: age and type of centre.
The variable "type of centre" was included because the risk of malignancy is likely to be higher in oncology centres than in other centres even after adjusting for clinical and ultrasound characteristics. We chose to add type of centre as a predictor rather than to develop separate models for oncology centres and other hospitals. Developing separate models means that sample size is reduced, mainly for the non-oncology hospitals. This would increase the possibility of overfitting. Developing one model with type of centre as a predictor assumes that the effects of clinical and ultrasound predictors are the same in both types of centres, an assumption that we consider plausible.
Appendix C: Shrinkage factors
We multiplied the predictor coefficients with uniform 'shrinkage factors' to avoid exaggerated model coefficients. 4 shadows, and ascites), two for the four predictors for which a first degree polynomial was allowed in the multivariable fractional polynomial procedure (age, serum CA-125, maximum diameter of the lesion, and number of papillary projections), and four for the predictor for which a second degree polynomial was allowed (proportion of solid tissue). 6 After fitting the random intercepts multinomial logistic regression model, we multiplied the obtained coefficients with the appropriate shrinkage factor. Then, we re-estimated model intercepts accordingly such that the average value of the linear predictors after shrinkage equal the average value of the fitted model without shrinkage. Table S1 . Prevalence of specific pathologies in the pooled data (N=5909) and separately for patients from oncology centres and other hospitals. Table S4 . Discrimination performance of the model without CA-125 as a predictor as obtained on the validation data and after retraining on the pooled data. For five tumour types, the Polytomous Discrimination Index for random prediction equals 0.2, hence its value cannot be directly compared with the AUCs. 95% confidence intervals are shown in parentheses Figure S1 . Forest plot with centre-specific areas under the receiver operating characteristic curve (AUC) with regard to discrimination between benign and malignant tumours. Results for the validation data are presented. The AUC is consistent over centres, notwithstanding the variability observed for centres that contributed few patients. NC, not computed. Figure S2 . Calibration plots of the predicted risks for each type of tumour in oncology centres. Data have been calculated using the validation data (n=1715). The plots show how well the predicted probabilities (x-axis) agree with the observed probabilities (yaxis). For perfect agreement, the calibration curve falls on the ideal diagonal line. The histograms below the plots show the distribution of the estimated risks. Figure S3 . Calibration plots of the predicted risks for each type of tumour in other than oncology centres. Data have been calculated using the validation data (n=688). The plots show how well the predicted probabilities (x-axis) agree with the observed probabilities (y-axis). For perfect agreement, the calibration curve falls on the ideal diagonal line. The histograms below the plots show the distribution of the estimated risks. For this subgroup the results contain a fair degree of uncertainty due to limited number of malignancies.
